Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Evaluation of BOTOX and Dysport in Temporal Brow Elevation
2005-005252-40Phase 2Completed
- Sponsor
- Aalst Dermatology Group
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in facial aging, Brow ptosis, sponsored by Aalst Dermatology Group. Started Dec 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
facial agingBrow ptosis
Beyond the preview
Go deeper on 2005-005252-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005252-40.